ETPN-FP8-Consultation

Contact Details

Drop us your contact details if you like!

Firstname

No firstname

Lastname

No lastname

Email

About yourself

Indicate the type of institution you are related to: (Required)

Larger Industry
SME
University or RESEARCH CENTERS
Hospital or Clinic
Other Institution

What is your main target in Nanomedicine (Required)

Research
Products
Regulation
Policy

Which area of Nanomedicine are your interested in? (Required)

Nano-Diagnostics
Nano-Pharmaceutics
Regenerative Medicine

General Questions

Do you feel Europe is competitive in terms of translation of Nanomedicine into real clinical application...and why? (Required)

In Asia the linkage between industry and academia is extremely close. Do you think this is a good idea? (Required)

Do you think the description of Nanomedicine is clear and understood. (Required)

Towards Framework Programme 8

Nanomedicine to be beneficial for patients needs industrial success. Would you be happy with a more industrial based transparent peer review system of project proposals? (Required)

Yes
No

Do you think retired industrial representatives should be involved in the review panels? (Required)

Yes
No

Do you think reimbursing industry for guiding academia would improve translation? (Required)

Yes
No

Do you think funding for Nanomedicine related projects needs to increased? (Required)

Yes
No

Do you think that current project funding schemes (IP, STREP, etc.) are adequate for your needs or would you like to see novel funding measures implemented (e.g. JTIs, Large scale industrial projects, etc.)? Please suggest! (Required)

Do you think Nanomedicine rather belongs to the Health area or to the Industrial Technologies area? (Required)

Yes
No

Which topics of Nanomedicine have not (yet) been addressed adequately by the past funding programmes of the EC (FP5,6,7). (Required)

Is there a need for novel (Research-)Infrastructures in Europe? If yes what kind of infrastructures? (Required)

Advancing Nanomedicine

What could the ETP Nanomedicine do to help more? (Required)

What could funding agencies do to help more? (Required)

What can researchers do to help more? (Required)

What can industry do to help more? (Required)

General Needs for translation in Nanomedicine

Are you genuinely interested in translation of your Nanomedicine projects into clinical or pharmaceutical products? (Required)

Yes
No

Do you have a “translation checklist” and knowledge or access to knowledge of what is required? (Required)

Yes
No

Do you think that access to translation advisors would be helpful? (Required)

Yes
No

If you had this advice would you take it into serious consideration? Even for example if the advice was to move field of research. (Required)

Yes
No

Requirements of industry for succesfull translation in Nanomedicine

What would be necessary for industry to invest more in the EU? (Required)

How can the EC support translation in your area better? (e.g. new funding programmes, infrstructure, coordination) (Required)

Does Open Innovation effect your way of thinking about research partnerships? Why? (Required)

Add-On questions related to “Translation”:

If you are an SME do you understand the requirements to develop your technology for a highly regulated market such as medicine and pharma? What kind of support would be beneficial? (Required)

If you belong to an academic group or an SME do you have ongoing two way communication with Pharma and/ or what is missing? (Required)

Do you understand that industry needs a high level of innovation (Unique Selling Proposition) and not incremental research for reimbursement? (Required)

Yes
No

Have you (Required)

	Yes	No
...considered how safe your nanomedicine is likely to be?
...considered whether it is manufacturable under current regulations
...considered what are the competitive products and what are your advantages
...considered whether such a product may be reimbursed.
...done a crude cost benefit analysis
...considered whether there is a commercial need or a societal benefit.